Similar articles

• Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression.

  Howell TH, Williams RC. Howell TH, et al. Crit Rev Oral Biol Med. 1993;4(2):177-96. doi: 10.1177/10454411930040020301. Crit Rev Oral Biol Med. 1993. PMID: 8435465 Review.
• [Nonsteroidal anti-inflammatory drugs in therapy of periodontal disease].

  Belardo S, Guida L, Labella R. Belardo S, et al. Arch Stomatol (Napoli). 1990 Apr-Jun;31(2):307-16. Arch Stomatol (Napoli). 1990. PMID: 2097949 Review. Italian. No abstract available.
• Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases.

  Paquette DW, Williams RC. Paquette DW, et al. Periodontol 2000. 2000 Oct;24:239-52. doi: 10.1034/j.1600-0757.2000.2240112.x. Periodontol 2000. 2000. PMID: 11276870 Review.
• A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis.

  Jeffcoat MK, Reddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP, Nelson SL, Goodale MB, Wehmeyer KR. Jeffcoat MK, et al. J Periodontol. 1995 May;66(5):329-38. doi: 10.1902/jop.1995.66.5.329. J Periodontol. 1995. PMID: 7623251 Clinical Trial.
• Flurbiprofen--a new anti-prostaglandin anti-inflammatory drug in rheumatoid arthritis.

  Gulati PD, Sharma RK, Sood KC, Rizvi SN. Gulati PD, et al. J Assoc Physicians India. 1981 Aug;29(8):603-7. J Assoc Physicians India. 1981. PMID: 7040332 Clinical Trial. No abstract available.